Jaguar Animal Health, Inc. (JAGX) vs Mustang Bio, Inc. (MBIO)
Jaguar Animal Health, Inc. and Mustang Bio, Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and Mustang Bio, Inc. are of similar size ($4.0M and $3.8M). Mustang Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.1×. Mustang Bio, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 14 metrics below, Mustang Bio, Inc. leads on 11 and Jaguar Animal Health, Inc. on 3.
Valuation
Profitability
| Metric | JAGX | MBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 82.31% | 0.00% | 65.16% |
| Operating margin | (93.10%) | 0.00% | 0.00% |
| Net margin | (188.46%) | 0.00% | 0.00% |
| Free cash flow margin | (24.03%) | 0.00% | 0.00% |
| Return on equity | (1,125.38%) | (58.12%) | (57.72%) |
| Return on assets | (127.14%) | (21.17%) | (49.22%) |
| Return on invested capital | (28,393.64%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack